[HTML][HTML] Trends in the development of remdesivir based inventions against COVID-19 and other disorders: A patent review

M Imran, AS Alshrari, SMB Asdaq - Journal of Infection and Public Health, 2021 - Elsevier
The development of remdesivir has been a breakthrough for COVID-19 treatment. It has
been approved in about 50 countries, including Saudi Arabia, since 2020. The generic …

Repurposing of antiviral drugs for COVID-19 and impact of repurposed drugs on the nervous system

M Punekar, M Kshirsagar, C Tellapragada, K Patil - Microbial Pathogenesis, 2022 - Elsevier
Abstract The recent pandemic, Coronavirus Disease 2019 (COVID-19) caused by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has devastated humanity and is …

Caspases and therapeutic potential of caspase inhibitors in moderate–severe SARS‐CoV‐2 infection and long COVID

M Plassmeyer, O Alpan, MJ Corley, TA Premeaux… - Allergy, 2022 - Wiley Online Library
Background COVID‐19 can present with lymphopenia and extraordinary complex
multiorgan pathologies that can trigger long‐term sequela. Aims Given that inflammasome …

Therapeutic and anti-inflammatory effects of baricitinib on mortality, ICU transfer, clinical improvement, and CRS-related laboratory parameters of hospitalized patients …

S Tahsini Tekantapeh, M Ghojazadeh… - Expert Review of …, 2022 - Taylor & Francis
Background Due to the high incidence and mortality of the worldwide COVID-19 pandemic,
beneficial effects of effective antiviral and anti-inflammatory drugs used in other diseases …

COVID-19: the epidemiology and treatment

L Qu, J Li, H Ren - British Journal of Hospital Medicine, 2020 - magonlinelibrary.com
After initially emerging in late 2019, coronavirus disease 2019 (COVID-19), caused by the
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has spread rapidly to …

Current and future direct-acting antivirals against COVID-19

SW Chan - Frontiers in Microbiology, 2020 - frontiersin.org
The coronavirus disease of 2019 (COVID-19) has caused an unprecedented global crisis.
The etiological agent is a new virus called the severe acute respiratory syndrome …

[HTML][HTML] COVID-19-induced seizures: a meta-analysis of case series and retrospective cohorts

H Hussaini, S Rogers, S Kataria, K Uddin… - Cureus, 2022 - ncbi.nlm.nih.gov
The adverse events and complications of coronavirus disease 2019 (COVID-19) continue to
challenge the medical profession despite the worldwide vaccination against the severe …

[PDF][PDF] Treatment modalities of the covid-19 pandemic through repurposed drugs and status of vaccines

MS Hussain, PP Mohit… - International Journal of …, 2021 - pdfs.semanticscholar.org
Respiratory diseases are the leading source of morbidity and death for millions around the
world of all ages. A 2019 coronavirus outbreak has occurred in China and is spread quickly …

Mesenchymal stromal cells and pleiotropic therapeutic advantages in COVID-19 management

VK Singh, UKS Vaksh, P Sharma - Stem Cells, 2024 - Elsevier
The pandemic burst of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or
coronavirus disease 2019 (COVID-19) infections shattered existing medical and research …

[HTML][HTML] Mesenchymal stem cells and COVID-19: What they do and what they can do

E Abu-El-Rub, RR Khasawneh… - World journal of stem …, 2021 - ncbi.nlm.nih.gov
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or coronavirus disease
2019 (COVID-19) pandemic has exhausted the health systems in many countries with …